Salix, Progenics advance on Relistor label expansion - Salix - TopicsExpress



          

Salix, Progenics advance on Relistor label expansion - Salix Pharmaceuticals Ltd. (NASDAQ:SLXP) and Progenics Pharmaceuticals Inc. (NASDAQ:PGNX) rose in midday trading after saying federal regulators signaled they will approve their drug Relistor for treatment of chronic pain in non-cancer patients. Salix gained 2.8 percent to $135.48, while Progenics jumped 9.4 percent to $4.64 at 1:47 p.m. in New York. The Food and Drug Administration is requiring some post-marketin... ow.ly/2K8QRX
Posted on: Mon, 14 Jul 2014 18:22:52 +0000

Trending Topics



Recently Viewed Topics




© 2015